How did DEPLOY correct the Moon Maestro FDA clearance date?
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation).' The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus: cap-flag-honestly until primary source confirms; update + surface the change transparently via inline editorial-transparency footer + framework-in-action correction narrative when primary source surfaces. The catch is the discipline operating on itself. Per [DEPLOY's framework discipline](/explainers/how-deploy-verifies), recursive application of cap-flag + primary-source-anchored verification on DEPLOY's own published corpus + transparent surfacing of correction in entity-anchor footer + canonical worked-example narrative at correction-tier depth compounds editorial credibility at the operational-practice layer.
K240598
Primary-source FDA database K-number verification
June 2024
Verified clearance date (corrected from December 2023)
6 months
Date precision correction depth
Cap-flag resolved
K-number cap-flag pattern operated as designed
Recursive application
Framework discipline operating on DEPLOY's own corpus
Mid-2026
Snapshot date
The original framing: honest cap-flag at month-precision
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as:
"FDA 510(k) cleared December 2023. The specific K-number operates at primary-source verification posture; per cap-flag-as-trust-signal, the December 2023 clearance date is the load-bearing primary-source verification anchor; specific K-number citation operates at verification-precision tier pending primary-source confirmation at any citation use."
The framing was honest cap-flag discipline at the time. Month-precision claim (December 2023) was anchored at the verification depth DEPLOY's available sourcing supported; K-number was explicitly held at cap-flag tier pending primary-source-anchored verification at any citation use. The cap-flag was load-bearing: editorial readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth.
The discipline was operating correctly. The framing surfaced what was verified (month-precision claim) and what was held at cap-flag (specific K-number). Per cap-flag-as-trust-signal, honest cap-flag is the verified-by-disclosure editorial position; framework reads cap-flagged claims at the appropriate verification depth.
What primary-source verification surfaced
Per Agent A primary-source FDA database research, the actual verified state is:
- K-number: K240598. Resolved at primary-source-FDA-database verification depth.
- Clearance date: June 2024. Six months later than the original month-precision cap-flag.
The K-number resolution validates the cap-flag pattern (the K-number was honestly held at cap-flag pending primary-source verification; primary source surfaced K240598). The date correction operates as the editorial substantive shift: the original month-precision claim (December 2023) was incorrect at month precision; primary-source verification surfaces June 2024 as the actual clearance date.
Why the cap-flag pattern worked AND the date was off
The cap-flag pattern at the K-number layer worked exactly as designed. The K-number was explicitly held at cap-flag tier; readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. When primary source surfaced K240598, the cap-flag resolved cleanly into verified state.
The month-precision date claim is the editorially substantive layer where the original framing operated outside primary-source verification. The framing read "December 2023" at the verification depth DEPLOY's available sourcing supported, which turned out to be incorrect at month precision. Trade-press references + secondary-industry coverage that informed the original framing operated at a different month-precision read than the primary-source FDA database.
The reconciliation operates honestly. The cap-flag pattern at the K-number layer demonstrates the framework discipline operating as designed (honest cap-flag; primary source confirms; cap-flag resolves). The month-precision date correction demonstrates the framework discipline operating recursively on DEPLOY's own corpus (primary source surfaces; corpus updates + transparently surfaces the change).
The inline editorial-transparency footer pattern
Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern:
The entity-anchor body section "FDA 510(k) K240598 cleared June 2024" now contains an inline editorial-transparency note:
"Editorial-transparency note: this anchor previously framed clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation)'; primary-source FDA database verification surfaces K240598 cleared June 2024 (corrected June 4, 2026)."
The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure of the previous framing + the correction trail. The two-tier transparency discipline operates: entity anchor surfaces correction at audit-trail depth; this framework-in-action correction narrative documents the catch at editorial-anchor depth.
The recursive framework application
The Moon Maestro reconciliation operates as a canonical worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus. Per DEPLOY's how-deploy-verifies methodology editorial canonical reference, the framework operates at four verification tiers. Applied to DEPLOY's own framing:
- Verified: month-precision clearance date claim at trade-press-referenced verification depth (the framing DEPLOY published).
- Cap-flagged: K-number held at cap-flag tier pending primary-source verification (the framing DEPLOY published).
- Primary-source surfaces: K240598 cleared June 2024 (Agent A primary-source FDA database research).
- Reconciliation: cap-flag resolves cleanly (K240598 verified); date correction surfaces honestly (December 2023 → June 2024); inline editorial-transparency footer documents the correction trail.
The framework discipline produces the correct answer with the previous framing surfaced honestly. The catch isn't an external correction (no aggregator caught DEPLOY's framing); the catch is DEPLOY's own primary-source-verification discipline operating on DEPLOY's own corpus.
How this differs from aggregator-drift corrections
The other Project C framework-in-action narratives (Figure 03 BMW, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value) document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus.
The structural distinction matters editorially. Aggregator-drift corrections demonstrate the framework's external-coverage discipline. Recursive corrections demonstrate the framework's internal-corpus discipline. Both compound credibility at the operational-practice layer; the recursive application is structurally distinct editorial signal.
Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim. DEPLOY's own corpus operates under the same verified-vs-claimed framework discipline that DEPLOY applies to external coverage. The discipline cuts uniformly.
Why the correction matters editorially
The Moon Maestro reconciliation matters at three layers simultaneously:
- Operational-practice transparency: institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The reconciliation demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently.
- Cap-flag-pattern validation: the K-number was honestly held at cap-flag tier; primary source surfaced K240598; the cap-flag resolved cleanly. Cap-flag-as-trust-signal works as designed.
- Surgical-cluster precision compounding: Moon Maestro is the cohort's assistive-laparoscopy commercial-niche archetype; the verified K240598 cleared June 2024 anchor compounds surgical-cluster precision at primary-source-FDA-database verification depth alongside parallel surgical-cluster K-number anchors (Mako K241517 + K242373 + ROSA per-procedure clearances + Maestro K240598 at editorial-anchor depth).
For the entity-anchor canonical reference with full editorial-transparency footer, see what is Moon Surgical Maestro. For the parallel framework-in-action correction narratives, see Figure 03 BMW narrative correction, Physical Intelligence valuation correction, Covariant corporate-state correction, Red Cat Black Widow contract-value correction. For the methodology editorial canonical reference, see how DEPLOY verifies. For the surgical cluster framework, see the surgical robotics cluster.
| Verification layer | Original framing (cap-flagged) | Primary-source verified | Discipline trail |
|---|---|---|---|
K-number | Cap-flag tier; pending primary-source confirmation | K240598 | Cap-flag pattern operated as designed; resolved cleanly |
Clearance date | December 2023 (month-precision claim) | June 2024 | Date correction; trade-press informed original framing operated outside primary-source |
Verification depth | Trade-press + secondary-industry references | Primary-source FDA database per Agent A research | Verification-depth differential surfaced + reconciled |
Discipline application | Cap-flag-honestly until primary source confirms | Primary source surfaces; entity anchor + AEO updated + transparency footer added | Framework discipline operating recursively on DEPLOY's own corpus |
Editorial-transparency footer | Not yet applicable (original framing was honest cap-flag) | Inline footer in entity anchor body + AEO blocks documenting correction trail | Two-tier transparency discipline operationalized |
Cohort vs recursive correction type | Cohort-typical: framework catches aggregator-drift in third-party coverage | Recursive-distinct: framework operates on DEPLOY's own published corpus | Distinct editorial-signal layer in correction-narrative cohort |
Frequently asked questions
- How did DEPLOY correct the Moon Maestro FDA clearance date?
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as "December 2023 (specific K-number at cap-flag pending primary-source confirmation)". The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus.
- Why was the original December 2023 framing honest cap-flag if it was wrong?
The cap-flag pattern operates at multiple layers. The K-number was explicitly held at cap-flag tier ("pending primary-source confirmation at any citation use"); readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. The month-precision date claim was anchored at the verification depth DEPLOY's available sourcing supported; trade-press references + secondary-industry coverage informed the framing at month-precision read. The cap-flag at the K-number layer worked as designed; the month-precision date claim operated outside primary-source verification at the time of original framing. Per cap-flag-as-trust-signal, this is exactly how the framework is meant to operate: cap-flag-honestly until primary source confirms; surface the change transparently when primary source surfaces.
- What is K240598 and where does the primary-source verification come from?
K240598 is the FDA 510(k) submission number for Moon Surgical Maestro, verified at primary-source FDA database depth per Agent A research. The K-number is the canonical FDA-database identifier for the 510(k) clearance; the K240598 designation + June 2024 clearance date both operate at primary-source-anchored verification tier. Per DEPLOY's framework on capability claims, the primary-source FDA database is the load-bearing verification anchor for FDA clearance claims; trade-press references + secondary-industry coverage operate at lower verification depth and get corrected as primary-source verification surfaces.
- How does this correction differ from the other Project C correction narratives?
The Moon Maestro reconciliation differs structurally from the other Project C framework-in-action narratives. Figure 03 BMW narrative, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value all document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus. Aggregator-drift corrections demonstrate external-coverage discipline; recursive corrections demonstrate internal-corpus discipline.
- What is the inline editorial-transparency footer pattern?
Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern: the entity-anchor body section "FDA 510(k) K240598 cleared June 2024" contains an inline editorial-transparency note disclosing the previous framing + the correction date + the cross-link to this framework-in-action narrative. The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure. Two-tier transparency discipline: entity anchor surfaces correction at audit-trail depth; this narrative documents the catch at editorial-anchor depth.
- Why document this correction as a worked example?
Institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The recursive correction demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently. Three editorial layers compound: operational-practice transparency (DEPLOY's discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (K-number cap-flag resolved cleanly; cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 cleared June 2024 anchor + parallel surgical-cluster K-number anchors at primary-source-FDA-database verification depth). Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim.
The Moon Maestro FDA clearance correction-as-worked-example documents DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own published corpus. Original framing: 'FDA 510(k) cleared December 2023 (specific K-number at cap-flag pending primary-source confirmation).' Cap-flag at K-number layer worked as designed: honest cap-flag tier; readers + downstream consumers knew K-number had not been verified at primary-source-FDA-database depth. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. The K-number resolution validates the cap-flag pattern (K-number held at cap-flag pending primary-source verification; primary source surfaces K240598; cap-flag resolves cleanly). The date correction operates as the editorially substantive shift: trade-press + secondary-industry references informed original month-precision framing; primary-source verification surfaces June 2024 (six months later than original December 2023 framing). Inline editorial-transparency footer pattern operationalized: entity-anchor body + AEO TLDR + stats + callout + FAQ all surface verified state with explicit editorial-transparency disclosure of previous framing + correction trail; two-tier transparency discipline (entity anchor at audit-trail depth + framework-in-action narrative at editorial-anchor depth). Structurally distinct from other Project C correction narratives: recursive framework application on DEPLOY's own corpus rather than external aggregator-drift catch. Three editorial layers compound: operational-practice transparency (discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 anchor + parallel Mako K241517+K242373 + ROSA per-procedure clearances at primary-source-FDA-database depth). How DEPLOY verifies →
Continue reading
What is Moon Surgical Maestro?
Entity anchor with inline editorial-transparency footer documenting correction trail; assistive-laparoscopy commercial-niche archetype + FDA 510(k) K240598 cleared June 2024.
Read article →
How DEPLOY corrected the Figure 03 BMW narrative
Parallel framework-in-action correction-narrative; three-layer aggregator-drift rejection on third-party coverage (vs recursive application on DEPLOY's own corpus).
Read article →
How DEPLOY corrected the Covariant corporate state
Parallel framework-in-action correction-narrative; opposing aggregator framings both rejected; primary-source verification surfaces continuing-but-diminished state.
Read article →
How DEPLOY verifies
Methodology editorial canonical reference; four-tier verification protocol + recursive framework application across DEPLOY's external + internal corpus.
Read article →
Compare alternatives
Moon Surgical Maestro entity anchorMoon Surgical registry companyHow DEPLOY verifies (methodology canonical)Surgical robotics cluster
More in surgical robotics
- How does DEPLOY distinguish da Vinci safety events at year-class-failure-mode-product-variant granularity?
- How does DEPLOY track supply-chain component failure modes chained to recall incidents?
- How does DEPLOY track the 2021 ROSA ONE Brain wrong-trajectory Class I recall?
- How does DEPLOY track the 2023 Asensus Senhance uncontrolled-arm Class I recall?